Compare OXBR & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OXBR | IMCC |
|---|---|---|
| Founded | 2013 | 1980 |
| Country | Cayman Islands | Israel |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 10.4M |
| IPO Year | 2014 | N/A |
| Metric | OXBR | IMCC |
|---|---|---|
| Price | $1.41 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 19.3K | ★ 127.8K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,423,000.00 | ★ $37,606,703.00 |
| Revenue This Year | $497.99 | $47.12 |
| Revenue Next Year | $42.14 | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $1.12 | $0.93 |
| 52 Week High | $5.81 | $7.12 |
| Indicator | OXBR | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 49.71 | 56.25 |
| Support Level | $1.30 | $1.65 |
| Resistance Level | $1.42 | $1.84 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 77.33 | 85.26 |
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.